Venture startup

Who invested in Vitae Industries

One round we have observed, with the 5 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Pharma

Funding summaryUpdated 26 Oct 2026

Undisclosedraised across 1 round since 2019, from 1 source

Latest round
VentureJun 2019
Investors
5
See who backed them

The rounds

  1. Jun 2019

Founders and team

From Vitae Industries's own website and the SEC filings it signed: 2 founders, 3 on the team.

Anthony MarsellaCEO, Co-Founder
Daniel DeCiccioCo-Founder & CTONamed on its 2017 Form D
  • Jeanine Sinanan-SinghChief Executive Officer, President, and Directori
  • Stuart JamiesonCFO
  • Thomas DePetrilloPartner & Board Chairman

Everyone who backed them

TechstarsVC firm1round
BoxGroupVC firm1round
Founder CollectiveVC firm1round
Lerer HippeauVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Vitae Industries as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

Slater Technology FundGovernmentPer its own site

Quick answers about Vitae Industries

Who invested in Vitae Industries?

Vitae Industries's investors include Techstars, Right Side Capital Management, BoxGroup, Founder Collective and Lerer Hippeau.

How much has Vitae Industries raised?

Vitae Industries has raised 1 round since 2019, none with a disclosed amount.

When did Vitae Industries last raise?

Vitae Industries's most recent round was a Venture in Jun 2019.

Who backed Vitae Industries first?

Vitae Industries's first round on record, in Jun 2019, was backed by Techstars, Right Side Capital Management and BoxGroup and 2 others.

What stage is Vitae Industries at?

Vitae Industries's latest named round is a Venture, in Jun 2019.

Companies like Vitae Industries

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.